MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-30-2026
TherapeuticsMD DPO Ratio 2011-2026 | TXMD
Annual DPO Ratio TherapeuticsMD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 723 | 3.18 K | 481 | 1.11 K | 3.03 K | 567 | 642 | 253 | 629 | 394 | 444 | 118 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.18 K | 118 | 964 |
Quarterly DPO Ratio TherapeuticsMD
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | 3.53 K | 4.55 K | 2.7 K | - | 295 | 275 | 305 | - | 586 | 437 | 676 | - | 1.21 K | 1.4 K | 2.51 K | - | 2.97 K | 4.57 K | 1.93 K | - | 534 | 548 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.57 K | 275 | 1.71 K |
DPO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
38 | - | 7.5 % | $ 6.35 M |  USA |
 |
Assertio Holdings
ASRT
|
122 | $ 18.41 | -1.02 % | $ 118 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
345 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
116 | - | - | $ 754 M | USA |
 |
Catalent
CTLT
|
41.8 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
519 | - | - | $ 50.1 M | USA |
 |
Endo International plc
ENDP
|
39.3 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
5.36 K | - | - | $ 36.6 M | USA |
 |
Agile Therapeutics
AGRX
|
352 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
309 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
111 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
224 | - | - | $ 2.06 B |  France |
 |
Cumberland Pharmaceuticals
CPIX
|
775 | $ 3.14 | 2.28 % | $ 44.1 M | USA |
 |
Jupiter Wellness
JUPW
|
318 | - | - | $ 33.6 M | USA |
 |
Cronos Group
CRON
|
212 | $ 2.53 | 0.4 % | $ 1.33 B |  Canada |
 |
Bausch Health Companies
BHC
|
78.1 | $ 5.35 | 1.71 % | $ 1.95 B | Canada |
 |
Aurora Cannabis
ACB
|
-807 | $ 3.43 | 1.78 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
52.8 | $ 1.04 | 4.83 % | $ 112 M | Canada |
 |
PetIQ
PETQ
|
54.2 | - | 1.64 % | $ 400 M | USA |
 |
ProPhase Labs
PRPH
|
45.4 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
274 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
6.63 | - | -4.76 % | $ 65.3 M | USA |
 |
Harrow Health
HROW
|
199 | $ 36.73 | 3.67 % | $ 1.35 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
75.6 | - | -39.89 % | $ 27.7 M | USA |
 |
Evolus
EOLS
|
59.4 | $ 4.09 | 0.25 % | $ 264 M | USA |
 |
Emergent BioSolutions
EBS
|
55.8 | $ 8.39 | 6.88 % | $ 430 M | USA |
 |
Organogenesis Holdings
ORGO
|
94 | $ 2.39 | 5.75 % | $ 315 M | USA |
 |
Pacira BioSciences
PCRX
|
37.3 | $ 23.25 | 3.2 % | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
20.2 | $ 1.0 | 3.87 % | $ 49.9 M | USA |
 |
Lannett Company
LCI
|
36.8 | - | 1.15 % | $ 7.11 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
32.3 | $ 2.29 | 3.62 % | $ 2.84 M | USA |
 |
Tilray
TLRY
|
53 | $ 6.75 | 4.49 % | $ 4.17 B | Canada |
 |
Veru
VERU
|
264 | $ 2.55 | 2.82 % | $ 344 M | USA |
 |
OptiNose
OPTN
|
194 | - | - | $ 1.08 B | USA |
 |
Viatris
VTRS
|
64 | $ 13.57 | 3.12 % | $ 16.3 B | USA |
 |
cbdMD
YCBD
|
84 | $ 0.7 | -0.19 % | $ 3.02 M | USA |
 |
Zomedica Corp.
ZOM
|
64.3 | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
15.4 | $ 0.94 | -1.12 % | $ 33.8 M | USA |
 |
China Pharma Holdings
CPHI
|
47.6 | $ 0.62 | 1.57 % | $ 2.66 M |  China |